Pharmacovigilance often focuses on drugs' inherent risks - side effects,...
Off-Label Marketing vs. Off-Label Use: A Thin Line in Pharmacovigilance
There’s a fine line between innovation and violation regarding drug...
Cardiac Toxicity that Redefined Pharmacovigilance
In the 1980s, two groundbreaking drugs, Seldane (Terfenadine) and Hismanal...
The Jarisch-Herxheimer Reaction or When Treatment Turns into a Crisis
Imagine you're treating an infection, and instead of feeling better,...
Long QT Syndrome: A Silent Risk in Pharmacovigilance
Long QT Syndrome (LQTS) is a silent yet potentially fatal...
Silicone Allergy: Rare but Real
Silicone is widely used for its versatility and compatibility with...
Cross-Resistance in Focus: How Anticonvulsants Affect Muscle Relaxant Efficacy
Imagine a patient on long-term anticonvulsant therapy who unexpectedly requires...
Polypharmacy and the Complex Maze of Drug Interactions in Pharmacovigilance
In an era when patients, especially the elderly, are often...
Hiccups as the Unlikely Adverse Drug Reaction That Won’t Quit
In the vast pharmacovigilance world, serious adverse reactions often take...
